Article
Increase in Efficacy of Checkpoint Inhibition by Cytokine-Induced-Killer Cells as a Combination Immunotherapy for Renal Cancer.
International journal of molecular sciences - 27 Apr 2020
Dehno Mojgan Naghizadeh, Li Yutao, Weiher Hans, Schmidt-Wolf Ingo G H
Abstract excerpt
Cytokine-induced killer (CIK) cells are heterogeneous, major histocompatibility complex (MHC)-unrestricted T lymphocytes that have acquired the expression of several natural killer (NK) cell surface markers following the addition of interferon gamma (IFN-γ), OKT3 and interleukin-2 (IL-2). Treatment with CIK cells demonstrates a practical approach in cancer immunotherapy with limited, if any, graft versus host...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
